Abiopharma

🔍 Arap Sobrinho Sami (Executive)

Company: Vale S.A. (VALE)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 12,990 shares of Common Shares at $16.1116 per share (Direct)
  Date: 2026-04-01 | Code: P | equity_swap_involved: 0 | shares_owned_after: 12,990.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 12,990 shares of Common Shares (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 25,980.00 | transaction_form_type: 4 | Footnotes: F2, F3

Footnotes:

• F1: For purposes of this Form 4, a conversion rate of USD $ 1.00 for each BRL 5.16 was used.
• F2: On April 1, 2026, the Reporting Person was granted restricted share units ("RSUs"). Each RSU represents a contingent right to receive one Common Share of Vale S.A. upon settlement.
• F3: Includes 12,990 Common Shares that are represented by RSUs granted on April 1, 2026. RSUs vest on April 1, 2029. Each RSU represents a contingent right to receive one Common Share of Vale S.A. upon settlement.